Interclade neutralization and enhancement of human immunodeficiency virus type 1 identified by an assay using HeLa cells expressing both CD4 receptor and CXCR4/CCR5 coreceptors

被引：21

作者：

Barin, F

Brunet, S

Brand, D

Moog, C

Peyre, R

Damond, F

Charneau, P

Barre-Sinoussi, F

机构：

[1] Univ Tours, Virol Lab, EA 3250, Tours, France

[2] INSERM, U544, Inst Virol, Strasbourg, France

[3] Hop Bichat, Virol Lab, F-75877 Paris, France

[4] Inst Pasteur, Unite Oncol Virale, F-75724 Paris, France

[5] Inst Pasteur, Unite Biol Retrovirus, Paris, France

来源：

JOURNAL OF INFECTIOUS DISEASES | 2004年 / 189卷 / 02期

关键词：

D O I：

10.1086/380099

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

We report on the development and evaluation of a human immunodeficiency virus (HIV) neutralization assay that uses P4P cells, which are CD4(+)CXCR4(+)CCR5(+) HeLa cells that carry the lacZ gene under the control of the HIV-1 long terminal repeat. The results of the present study suggest that the P4P assay can be used for the extensive study of both neutralizing and enhancing activity in serum samples from HIV-1-infected patients and from vaccinated individuals.

引用

页码：322 / 327

页数：6

共 50 条

[41] Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells
Xiao, XD
Kinter, A
Broder, CC
Dimitrov, DS
EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2000, 68 (03) : 133 - 138
[42] The simian immunodeficiency virus mnd(GB-1) strain uses CXCR4, not CCR5, as coreceptor for entry in human cells
Schols, D
De Clercq, E
JOURNAL OF GENERAL VIROLOGY, 1998, 79 : 2203 - 2205
[43] Characterization and biologic consequence of chemokine (CXCR4, CCR5 and CCR3) receptor and CD4 antigen expression on normal and malignant human hematopoietic cells.
Ratajczak, MZ
Lee, B
Ratajczak, J
Doms, R
Gewirtz, A
BLOOD, 1997, 90 (10) : 2114 - 2114
[44] Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1
Platt, EJ
Wehrly, K
Kuhmann, SE
Chesebro, B
Kabat, D
JOURNAL OF VIROLOGY, 1998, 72 (04) : 2855 - 2864
[45] Human immunodeficiency virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and β-chemokines
Olsson, J
Poles, M
Spetz, AL
Elliott, J
Hultin, L
Giorgi, J
Andersson, J
Anton, P
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (06): : 1625 - 1635
[46] Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 Δ32
Michael, NL
Nelson, JAE
Kewalramani, VN
Chang, G
O'Brien, SJ
Mascola, JR
Volsky, B
Louder, M
White, GC
Litman, DR
Swanstrom, R
O'Brien, TR
JOURNAL OF VIROLOGY, 1998, 72 (07) : 6040 - 6047
[47] Thermal Stability of the Human Immunodeficiency Virus Type 1 (HIV-1) Receptors, CD4 and CXCR4, Reconstituted in Proteoliposomes
Zhukovsky, Mikhail A.
Basmaciogullari, Stephane
Pacheco, Beatriz
Wang, Liping
Madani, Navid
Haim, Hillel
Sodroski, Joseph
PLOS ONE, 2010, 5 (10):
[48] A synthetic CD4–heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry
Françoise Baleux
Latino Loureiro-Morais
Yael Hersant
Pascal Clayette
Fernando Arenzana-Seisdedos
David Bonnaffé
Hugues Lortat-Jacob
Nature Chemical Biology, 2009, 5 : 743 - 748
[49] Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1
Keppler, OT
Welte, FJ
Ngo, TA
Chin, PS
Patton, KS
Tsou, CL
Abbey, NW
Sharkey, ME
Grant, RM
You, Y
Scarborough, JD
Ellmeier, W
Littman, DR
Stevenson, M
Charo, IF
Herndier, BG
Speck, RF
Goldsmith, MA
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (06): : 719 - 736
[50] Purified complexes of HIV-1 envelope glycoproteins with CD4 and CCR5(CXCR4): production, characterization and immunogenicity
Xiao, XD
Phogat, S
Shu, Y
Phogat, A
Chow, YH
Wei, OL
Goldstein, H
Broder, CC
Dimitrov, DS
VACCINE, 2003, 21 (27-30) : 4275 - 4284

← 1 2 3 4 5 →